Assembly Biosciences, Inc.

ASMB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$40-$61-$93-$130
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$3
Stock-Based Comp.$3$5$7$5
Change in WC-$12$76-$2-$11
Other Non-Cash-$2$2$4$45
Operating Cash Flow-$51$23-$84-$93
Investing Activities
PP&E Inv.-$0-$0-$0-$3
Net Acquisitions$0$0$2$2
Inv. Purchases-$91-$134-$28-$160
Inv. Sales/Matur.$131$65$117$188
Other Inv. Act.$0$0$0$1
Investing Cash Flow$40-$69$91$27
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$29$14$0$53
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$29$14$1$53
Forex Effect$0$0$0$0
Net Chg. in Cash$19-$33$7-$14
Supplemental Information
Beg. Cash$20$52$46$59
End Cash$38$20$52$46
Free Cash Flow-$51$22-$85-$96
Assembly Biosciences, Inc. (ASMB) Financial Statements & Key Stats | AlphaPilot